Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
OPK > SEC Filings for OPK > Form 8-K on 1-Apr-2014All Recent SEC Filings

Show all filings for OPKO HEALTH, INC.

Form 8-K for OPKO HEALTH, INC.


Change in Directors or Principal Officers, Regulation FD Disclosure, Financial

Item 5.02 Departure of Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement for Certain Officers.

On March 31, 2014, the Board of Directors of OPKO Health, Inc. (the "Company") approved the appointment of Adam Logal, 36, to the position of Senior Vice President, Chief Financial Officer, effective on April 1, 2014. Mr. Logal currently receives an annual base salary of $235,000, which is subject to increase in the discretion of the Board of Directors. He will also be eligible to participate in the Company's benefit and bonus programs offered by the Company to other executive officers from time to time.

Prior to Mr. Logal's appointment to the position of Senior Vice President, Chief Financial Officer, he served as the Company's Chief Accounting Officer and Treasurer since March 2007. From 2002 to 2007, Mr. Logal served in senior management of Nabi Biopharmaceuticals, a publicly traded, biopharmaceutical company engaged in the development and commercialization of proprietary products. Mr. Logal held various positions of increasing responsibility, last serving as Senior Director of Accounting and Reporting.

Mr. Logal replaces Juan F. Rodriguez, who on March 31, 2014, submitted his notice of resignation from his position as Senior Vice President, Chief Financial Officer of the Company to be effective on April 1, 2014, and upon the appointment of a new chief financial officer. In connection with his resignation, Mr. Rodriguez will provide consulting services to the Company on terms to be negotiated.

Item 7.01 Regulation FD Disclosure.

The Company issued a press release announcing Mr. Rodriguez's resignation and Mr. Logal's appointment effective April 1, 2014. A copy of that press release is furnished as exhibit 99.1 to this Current Report on Form 8-K.

The information contained in Item 7.01 to this Current Report on Form 8-K and Exhibit 99.1 attached hereto shall not be deemed "filed" for purposes of
Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing by the Company under the Act.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

          Exhibit No.    Description

                99.1     Press Release of the Company, dated April 1, 2014.

  Top of the Form

  Add OPK to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for OPK - All Recent SEC Filings
Copyright © 2015 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.